STOCK TITAN

Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Integra LifeSciences (NASDAQ: IART), a global medical technology leader, has announced its participation in the 2024 Wells Fargo Healthcare Conference. Lea Knight, the company's chief financial officer, is scheduled to present on September 4, 2024, at 1:30 PM ET.

Investors and interested parties can access a live webcast of the presentation through Integra's investor relations website. This event provides an opportunity for stakeholders to gain insights into the company's current status and future prospects directly from its financial leadership.

The presentation at this prestigious healthcare conference underscores Integra's commitment to transparency and engagement with the investment community, potentially impacting its market position and stock performance.

Integra LifeSciences (NASDAQ: IART), un leader globale nella tecnologia medica, ha annunciato la sua partecipazione alla Wells Fargo Healthcare Conference 2024. Lea Knight, il direttore finanziario dell'azienda, è prevista alla presentazione il 4 settembre 2024, alle 13:30 ET.

Investitori e parti interessate possono accedere a un webcast dal vivo della presentazione attraverso il sito web delle relazioni con gli investitori di Integra. Questo evento offre un'opportunità per le parti interessate di acquisire approfondimenti sulla situazione attuale e sulle prospettive future dell'azienda direttamente dal suo leadership finanziaria.

La presentazione a questa prestigiosa conferenza sanitaria sottolinea l'impegno di Integra per la trasparenza e il coinvolgimento con la comunità degli investimenti, potenzialmente influenzando la sua posizione di mercato e le performance delle azioni.

Integra LifeSciences (NASDAQ: IART), un líder global en tecnología médica, ha anunciado su participación en la Conferencia de Salud de Wells Fargo 2024. Lea Knight, la directora financiera de la empresa, está programada para presentar el 4 de septiembre de 2024, a la 1:30 PM ET.

Los inversores y las partes interesadas pueden acceder a un webcast en vivo de la presentación a través del sitio web de relaciones con inversionistas de Integra. Este evento brinda la oportunidad a los interesados de obtener información sobre el estado actual de la empresa y sus perspectivas futuras directamente de su liderazgo financiero.

La presentación en esta prestigiosa conferencia de salud subraya el compromiso de Integra con la transparencia y la participación de la comunidad inversora, lo que podría influir en su posición en el mercado y en el rendimiento de sus acciones.

Integra LifeSciences (NASDAQ: IART), 세계적인 의료 기술 리더,가 2024 웰스파고 헬스케어 컨퍼런스에 참여한다고 발표했습니다. Lea Knight, 회사의 최고 재무 책임자는 2024년 9월 4일 오후 1:30 ET에 발표할 예정입니다.

투자자와 관심 있는 분들은 Integra의 투자자 관계 웹사이트를 통해 발표의 실시간 웹캐스트에 접근할 수 있습니다. 이 이벤트는 이해관계자들이 회사의 현재 상태와 미래 전망에 대한 통찰력을 재무 리더십으로부터 직접 얻을 수 있는 기회를 제공합니다.

이 유명한 헬스케어 컨퍼런스에서의 발표는 투자 커뮤니티와의 투명성과 참여에 대한 Integra의 헌신을 강조하며, 이는 시장 위치와 주식 성과에 영향을 미칠 가능성이 있습니다.

Integra LifeSciences (NASDAQ: IART), un leader mondial en technologies médicales, a annoncé sa participation à la Conférence sur la santé de Wells Fargo 2024. Lea Knight, la directrice financière de l'entreprise, est prévue pour présenter le 4 septembre 2024 à 13h30 ET.

Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via le site web des relations avec les investisseurs d'Integra. Cet événement offre une opportunité aux parties prenantes d'obtenir des informations sur l'état actuel de l'entreprise et ses perspectives futures directement de son équipe dirigeante financière.

La présentation lors de cette prestigieuse conférence sur la santé souligne l'engagement d'Integra envers la transparence et l'engagement avec la communauté d'investissement, ce qui pourrait avoir un impact sur sa position sur le marché et la performance de ses actions.

Integra LifeSciences (NASDAQ: IART), ein führendes Unternehmen im Bereich Medizintechnologie, hat seine Teilnahme an der Wells Fargo Healthcare Conference 2024 bekannt gegeben. Lea Knight, die Finanzvorständin des Unternehmens, wird am 4. September 2024 um 13:30 Uhr ET präsentieren.

Investoren und interessierte Parteien können über die Website für Investorenbeziehungen von Integra auf einen Live-Webcast der Präsentation zugreifen. Diese Veranstaltung bietet Stakeholdern die Möglichkeit, direkt von der finanziellen Leitung des Unternehmens Einblicke in den aktuellen Stand und die zukünftigen Perspektiven zu erhalten.

Die Präsentation auf dieser renommierten Gesundheitskonferenz unterstreicht Engagensment von Integra für Transparenz und Kommunikation mit der Investmentgemeinschaft, was potenziell Einfluss auf ihre Marktposition und Aktienperformance haben kann.

Positive
  • None.
Negative
  • None.

PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer, will present at the Wells Fargo Healthcare conference on September 4, 2024 at 1:30pm ET.

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at https://investor.integralife.com/events-and-presentations.

About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit investor.integralife.com.  

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com   

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com  

Integra LifeSciences Holdings Corporation


FAQ

When is Integra LifeSciences (IART) presenting at the 2024 Wells Fargo Healthcare Conference?

Integra LifeSciences (IART) is presenting at the 2024 Wells Fargo Healthcare Conference on September 4, 2024, at 1:30 PM ET.

Who will be representing Integra LifeSciences (IART) at the 2024 Wells Fargo Healthcare Conference?

Lea Knight, the chief financial officer of Integra LifeSciences (IART), will be representing the company at the 2024 Wells Fargo Healthcare Conference.

How can investors access Integra LifeSciences' (IART) presentation at the 2024 Wells Fargo Healthcare Conference?

Investors can access a live webcast of Integra LifeSciences' (IART) presentation through the company's investor relations website at https://investor.integralife.com/events-and-presentations.

What is the significance of Integra LifeSciences (IART) participating in the 2024 Wells Fargo Healthcare Conference?

Integra LifeSciences' (IART) participation in the 2024 Wells Fargo Healthcare Conference demonstrates its commitment to investor engagement and provides an opportunity for the company to share insights with the investment community, potentially impacting its market position.

Integra LifeSciences Holdings

NASDAQ:IART

IART Rankings

IART Latest News

IART Stock Data

1.37B
77.58M
14.17%
95.09%
5.67%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
PRINCETON